Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Diabetologia

• Publication date

  1998-06-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s001250050910PMID 9541173
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in Type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning

  2004cited by this paper
• Counterregulatory Hormone Responses and Symptoms During Hypoglycaemia Induced by Porcine, Human Regular Insulin, and Lys(B28), Pro(B29) Human Insulin Analogue (Insulin Lispro) in Healthy Male Volunteers

  1997cited by this paper
• Proinsulin Immunoreactivity in Recent-Onset IDDM: The significance of insulin antibodies and insulin autoantibodies

  1996cited by this paper
• Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus.

  1995cited by this paper
• Upregulation of Blood-Brain Barrier GLUT1 Glucose Transporter Protein and mRNA in Experimental Chronic Hypoglycemia

  1995cited by this paper
• Insulin therapy.

  1995cited by this paper
• Hypoglycaemia unawareness.

  1994cited by this paper
• Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes.

  1994cited by this paper
• Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM

  1994cited by this paper
• Reversal of Hypoglycemia Unawareness, But Not Defective Glucose Counterregulation, in IDDM

  1994cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Compromised Hormonal Counterregulation, Symptom Awareness, and Neurophysiological Function After Recurrent Short-Term Episodes of Insulin-Induced Hypoglycemia in IDDM Patients

  1993cited by this paper
• Nocturnal Blood Glucose Control in Type I Diabetes Mellitus

  1993cited by this paper
• Meticulous Prevention of Hypoglycemia Normalizes the Glycemic Thresholds and Magnitude of Most of Neuroendocrine Responses to, Symptoms of, and Cognitive Function During Hypoglycemia in Intensively Treated Patients With Short-Term IDDM

  1993influential reference
• Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes.

  1993cited by this paper
• The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus.

  1993cited by this paper
• Induction of Hypoglycemia Unawareness by Asymptomatic Nocturnal Hypoglycemia

  1993cited by this paper
• Arterial, arterialized venous, venous and capillary blood glucose measurements in normal man during hyperinsulinaemic euglycaemia and hypoglycaemia

  1992cited by this paper
• Iatrogenic Hypoglycemia as a Cause of Hypoglycemia-Associated Autonomic Failure in IDDM: A Vicious Cycle

  1992cited by this paper
• Symptoms of Acute Insulin-Induced Hypoglycemia in Humans With and Without IDDM: Factor-Analysis Approach

  1991cited by this paper
• Hypoglycemia unawareness.

  1991cited by this paper
• Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group.

  1991cited by this paper
• Glycemic control and neuropsychologic function during hypoglycemia in patients with insulin-dependent diabetes mellitus.

  1990cited by this paper
• Role of Brain in Counterregulation of Insulin-Induced Hypoglycemia in Dogs

  1989cited by this paper
• Serum Noradrenaline is Composed of Plasma and Platelet Noradrenaline

  1989cited by this paper
• Effect of Intensive Insulin Therapy on Glycemic Thresholds for Counterregulatory Hormone Release

  1988cited by this paper
• Overnight Metabolic Control With Bedtime Injection of Intermediate-Acting Insulin or Continuous Subcutaneous Insulin Infusion

  1987cited by this paper
• Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus.

  1987cited by this paper
• Absorption kinetics and action profiles of intermediate acting human insulins.

  1987cited by this paper
• Absorption kinetics and action profiles of intermediate acting human insulins.

  1987cited by this paper
• Chronic hypoglycemia increases brain glucose transport.

  1986cited by this paper
• Pathogenesis and Prevention of the Dawn Phenomenon in Diabetic Patients Treated with CSII

  1986cited by this paper
• Hypoglycaemia and Diabetes

  1986cited by this paper
• Insulin Pharmacokinetics

  1984cited by this paper
• Pharmacokinetics of continuous subcutaneous insulin infusion

  1983cited by this paper
• Diagnosis and management of diabetic autonomic neuropathy.

  1982cited by this paper
• Absorption of isophane (NPH) insulin and its clinical implications.

  1982cited by this paper
• Radioimmunoassay for Pancreatic Glucagon Based on Specific Derivatisation of the Hormone

  1981cited by this paper
• Combined Continuous Subcutaneous Insulin Infusion and Multiple Subcutaneous Injections in Type I Diabetic Patients

  1981cited by this paper

• Noncanonical clock regulators control stress responses in digestive diseases.

  2025cites this paper
• Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review

  2022cites this paper
• Circadian Variation in Efficacy of Medications

  2020cites this paper
• Interventions That Restore Awareness of Hypoglycemia in Adults With Type 1 Diabetes: A Systematic Review and Meta-analysis

  2015cites this paper
• Mechanisms of hypoglycemia unawareness and implications in diabetic patients.

  2015cites this paper
• Insulin Therapy in Children and Adolescents with Type 1 Diabetes

  2014cites this paper
• 5. Nocturnal Hypoglycaemia

  2013cites this paper
• The effects of hypoglycaemia on vascular disease and the brain

  2012cites this paper
• An overview of insulin pump therapy: appropriate use of an expensive resource

  2012cites this paper
• Impaired awareness of hypoglycaemia: a review.

  2010cites this paper
• Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.

  2010cites this paper
• Criterios y fundamentos para la utilización de la bomba de insulina

  2009cites this paper
• Hypoglycemia unawareness syndrome. Risk factors and treatment

  2009cites this paper
• Differenzialindikationen und Relevanz der Pumpentherapie im Kindes- und Jugendalter

  2009cites this paper
• How hypoglycaemia can affect the life of a person with diabetes

  2008cites this paper
• Impaired Awareness of Hypoglycaemia

  2007cites this paper
• Metabolic control with insulin pump therapy: the Waikato experience.

  2007cites this paper
• CzŒstoúÊ, czas trwania i nastŒpstwa epizodÛw nocnej hipoglikemii u chorych na cukrzycŒ typu 1, ocenianych za pomoc" ci"g‡ego monitorowania stŒ¿enia glukozy

  2007cites this paper
• Basal insulin supplementation in Type 1 diabetic children: A long-term comparative observational study between continuous subcutaneous insulin infusion and glargine insulin

  2007cites this paper
• Indications for insulin pump therapy in different age groups—an analysis of 1567 children and adolescents

  2007cites this paper
• Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations

  2007cites this paper
• Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes.

  2006cites this paper
• Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study.

  2006cites this paper
• Nocturnal hypoglycemia in type 1 diabetes: an assessment of preventive bedtime treatments.

  2006cites this paper
• Type 1 Diabetes in Children, Adolescents, and Young Adults: How to Become an Expert on Your Own Diabetes

  2006cites this paper
• Continuous Blood Glucose Monitoring and Insulin Pumps

  2006cites this paper
• Counterregulatory responses in CSII

  2006cites this paper
• An observational study comparing continuous subcutaneous insulin infusion (CSII) and insulin glargine in children with type 1 diabetes

  2005cites this paper
• Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.

  2004cites this paper
• Hypoglycaemia unawareness.

  2004cites this paper
• Insulin pumps and pancreas transplantation for unstable and brittle diabetes

  2004cites this paper
• Hypoglycaemia unawareness in Type 1 diabetes and its management

  2004cites this paper
• Modeling β-Cell Insulin Secretion - Implications for Closed-Loop Glucose Homeostasis

  2003cites this paper
• Nocturnal hypoglycemia: clinical manifestations and therapeutic strategies toward prevention.

  2003cites this paper
• Insulin pump therapy in patients with Type 1 diabetes mellitus: results of the Nationwide Quality Circle in Germany (ASD) 1999-2000.

  2003cites this paper
• Insulin pump therapy: a meta-analysis: Response to Weissberg-Benchell et al. Authors' reply

  2003cites this paper
• Hypoglycemia in Type 1 Diabetes

  2003cites this paper
• Type 1 Diabetes

  2003cites this paper
• Insulin pump therapy: a meta-analysis.

  2003cites this paper
• Modest contribution of psychosocial variables to hypoglycaemic awareness in Type 1 diabetes.

  2002cites this paper
• Avoiding Nocturnal Hypoglycemia: Consideration of an Extra Injection at Bedtime

  2002cites this paper
• A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.

  2002cites this paper
• Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes.

  2002cites this paper
• Sweet dreams? – nocturnal hypoglycemia in children with type 1 diabetes

  2002cites this paper
• Night-time only insulin pump therapy in young children with type 1 diabetes mellitus

  2002cites this paper
• Administration of Neutral Protamine Hagedorn Insulin at Bedtime versus with Dinner in Type 1 Diabetes Mellitus To Avoid Nocturnal Hypoglycemia and Improve Control

  2002cites this paper
• Is There a Need for a Better Basal Insulin

  2001cites this paper
• ACE inhibition and renovascular disease

  2001cites this paper
• Physiological insulin replacement in type 1 diabetes mellitus.

  2001cites this paper
• Symptoms of hypoglycaemia in people with diabetes

  2001cites this paper
• New technologies and therapeutic approaches for the management of pediatric diabetes

  2001cites this paper
• View 2 Insulin Pump Therapy in Young Children With Diabetes

  2001cites this paper
• Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy.

  2001cites this paper
• Avoidance of Hypoglycemia Restores Hypoglycemia Awareness by Increasing -Adrenergic Sensitivity in Type 1 Diabetes

  2001cites this paper
• Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care.

  2001cites this paper
• Insulinanaloga: Struktur, Eigenschaften und therapeutische Indikationen Teil 1: Kurzwirkende Insulinanaloga

  2001cites this paper
• Type 1 diabetes mellitus in Czech children diagnosed in 1990–1997: a significant increase in incidence and male predominance in the age group 0–4 years

  2000cites this paper
• Optimized basal-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients: no favorable effects on glycemic control, physiological responses to hypoglycemia, well-being, or treatment satisfaction.

  2000cites this paper
• Hypoglycaemia--clinical consequences and morbidity.

  2000cites this paper
• Nighttime continuous subcutaneous insulin infusion revisited: a strategy for improving insulin delivery.

  2000cites this paper
• Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia.

  2000cites this paper
• Assessing impaired hypoglycemia awareness in type 1 diabetes: agreement of self-report but not of field study data with the autonomic symptom threshold during experimental hypoglycemia.

  2000cites this paper
• Use of insulin pump therapy at nighttime only for children 7-10 years of age with type 1 diabetes.

  2000cites this paper
• Insulin analogues and their potential in the management of diabetes mellitus

  1999cites this paper
• Insulin therapy in children and adolescents with Type 1 diabetes.

  1999cites this paper
• Klinische (Bio)chemie en Methodologie

  1999cites this paper
• Diabetes in the next century: challenges and opportunities.

  1999cites this paper
• Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.

  1999cites this paper
• Insulin pump therapy in Type 1 pediatric patients: now and into the year 2000

  1999cites this paper
• Pharmacodynamic aspects of modes of drug administration for optimization of drug therapy.

  1999cites this paper
• Hypoglycaemia associated syndrome

  1998cites this paper
• Hypoglycaemia avoidance--technology and knowledge.

  1998cites this paper
• Learning to use a new drug—the fast‐acting insulin analogues

  1998cites this paper
• diabetes Hypoglycemia unawareness syndrome . Risk factors and treatment

  year unknowncites this paper
• Assessing Impaired Hypoglycemia Aw a reness in Type 1 Diabetes

  year unknowncites this paper